UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Determining what age to move from stocks to bonds is vital for long-term financial health. Explore guidelines to help you plan your investment strategy.
23,118 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
As markets enter the quieter summer season, space-themed investing offers a targeted way to capture innovation. This ...
A landmark federal lawsuit puts civil rights under a new spotlight as the Trump-appointed EEOC chair sues The New Yor...
A regulatory push to index cost basis to inflation could reshape retiree taxes on big taxable sales, with Kiplinger c...
SpaceX’s Grok AI platform posted solid revenue yet massive losses in the latest quarter, raising questions about the ...
A high-profile crypto exposure is more than a headline. This deep dive unpacks what trump media moves over Bitcoin be...
Walmart is steering toward higher-margin online services and automation as it grows. The big question for investors i...
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
The future of urban air mobility hinges on regulatory progress and real-world adoption. This guide breaks down whethe...
A Cape Cod home tied to the Kennedy family quickly drew an offer after listing at $1.6 million, highlighting brisk co...
XRP spot ETFs surged to a 2026 weekly inflow record of $60.5 million, signaling renewed investor interest as the mark...
When personal life meets the public eye, money isn’t far behind. This article explores the financial fallout of high-...